GMRE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Global Medical REIT Inc (GMRE) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the technical indicators show bullish moving averages and insider buying activity is significantly up, the company's financial performance is concerning with a sharp decline in net income and EPS. Additionally, there are no strong proprietary trading signals or significant positive catalysts to justify immediate action. It is better to wait for the upcoming earnings release and assess the company's performance post-results before making a decision.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200) and a neutral RSI of 53.52. The MACD histogram is positive at 0.08, indicating mild bullish momentum. Key support and resistance levels are Pivot: 35.819, R1: 37.301, S1: 34.337, R2: 38.217, S2: 33.421. Overall, the technical indicators suggest a stable but not strongly bullish trend.
Insider buying activity has increased by 4132.36% over the last month, indicating confidence from insiders.
The company's name change to Chiron Real Estate Inc. and upcoming earnings release could potentially attract investor attention.
Financial performance is weak, with a significant decline in net income (-435.06% YoY) and EPS (-421.43% YoY).
The stock has a 50% chance of declining -3.23% in the next week based on historical patterns.
No recent congress trading data or significant hedge fund activity.
In Q3 2025, revenue increased by 8.65% YoY to $37.23M. However, net income dropped significantly to -$6.001M (-435.06% YoY), and EPS fell to -$0.45 (-421.43% YoY). Gross margin remained stable at 100%. Overall, the financials show revenue growth but severe profitability challenges.
No recent analyst rating or price target changes were provided. Wall Street sentiment appears neutral with no significant pros or cons highlighted.
